201196 cadmium (fluidigm)
86
Structured Review
fluidigm
201196 cadmium
201196 Cadmium, supplied by fluidigm, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/201196+cadmium/Cell-ID+Cisplatin-196Pt/pm36550781-48-245-255
Average 86 stars, based on 1 article reviews
201196 Cadmium, supplied by fluidigm, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/201196+cadmium/Cell-ID+Cisplatin-196Pt/pm36550781-48-245-255
Average 86 stars, based on 1 article reviews
201196 cadmium - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Mass Cytometry:Article Title: Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Article Snippet: .. Mass cytometry Marker Clone Metal Source Cat. no; home-made LOT identifier CD45 HI30 Y89 Fluidigm 3089003B CD28 CD28.2 142Nd Bxcell BE0291; 180116 CD49f GoH3 143Nd Biolegend 313602; 180906 CD69 FN50 144Nd Fluidigm 3144018B CD4 RPA-T4 145Nd Fluidigm 3145001B CD8a RPA-T8 146Nd Fluidigm 3146001B ITGB5 AST-3 T 147Sm Biolegend 345202; 180919 CD111 R1.302 148Nd Biolegend 340402;180906 CD38 HIT2 149Sm Exbio 11-366-C100, 190425 CD112 TX31 150Nd Biolegend 337402; 180919 EpCAM 9C4 152Sm Biolegend 324229; 180919 CD29 TS2/16 156Gd Fluidigm 3156007B ROR-1 2A2 159Tb Miltenyi Biotec 130-98-243; 191209 CD14 M5E2 160Gd Fluidigm 3160001B CD49c ASC-1 162Dy Biolegend 343802; 180906 CD24 ML5 165Ho Biolegend 311127; 181129 CD44 BJ18 166Er Fluidigm 3166001B CD90 5E10 167Er Biolegend 328129; 180919 CD19 HIB19 169Tm Fluidigm 3169011B CD3 UCHT1 170Er Fluidigm 3170001B CD97 VIM3b 171Yb Fluidigm 3171015B CD9 SN4_C3-3A2 172Yb Fluidigm 3172010B HLA-DR L243 174Yb Fluidigm 3174001B CD31 MEM-05 175Lu Exbio 11-273-C100; 190516 CD56 (NCAM) NCAM16.2 176Yb Fluidigm 3176008B aSMA 1A4 141Pr Fluidigm 3141017D pSmad1 (Ser463/465)/ Smad5 (Ser463/465)/ Smad9 (Ser465/467) D5B10 151Eu Cell Signaling #12428; 191209 Stat1 (Y701) 58D6 153Eu Fluidigm 3153003A Vimentin D21H3 154Sm Fluidigm 3154014A pSmad2 (Ser465/Ser467) E8F3R 155Gd Cell Signaling #18338; 181129 pStat3 (Y70) 4/P-STAT3 158Gd Fluidigm 3158005A pNF-kBp65 (S536) 93H1 161Dy Cell Signaling #3033;170313 pAkt (S473) D9E 163Dy Cell Signaling #4060; 170313 Active b-catenin (Ser45) D2U8Y 164Dy Cell Signaling #19807; 181129 Ki-67 B56 168Er Fluidigm 3168007B PanCK C-11 173Yb Exbio 11-108-C100; 180919 CD298 REA217 N/A Miltenyi 130-122-331; N/A HLA-I W6/32 N/A Bxcell BE0079; N/A Chemicals Platinum (195Pt, 196Pt) Fluidigm 201195, Marker:Article Title: Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Article Snippet: .. Mass cytometry Marker Clone Metal Source Cat. no; home-made LOT identifier CD45 HI30 Y89 Fluidigm 3089003B CD28 CD28.2 142Nd Bxcell BE0291; 180116 CD49f GoH3 143Nd Biolegend 313602; 180906 CD69 FN50 144Nd Fluidigm 3144018B CD4 RPA-T4 145Nd Fluidigm 3145001B CD8a RPA-T8 146Nd Fluidigm 3146001B ITGB5 AST-3 T 147Sm Biolegend 345202; 180919 CD111 R1.302 148Nd Biolegend 340402;180906 CD38 HIT2 149Sm Exbio 11-366-C100, 190425 CD112 TX31 150Nd Biolegend 337402; 180919 EpCAM 9C4 152Sm Biolegend 324229; 180919 CD29 TS2/16 156Gd Fluidigm 3156007B ROR-1 2A2 159Tb Miltenyi Biotec 130-98-243; 191209 CD14 M5E2 160Gd Fluidigm 3160001B CD49c ASC-1 162Dy Biolegend 343802; 180906 CD24 ML5 165Ho Biolegend 311127; 181129 CD44 BJ18 166Er Fluidigm 3166001B CD90 5E10 167Er Biolegend 328129; 180919 CD19 HIB19 169Tm Fluidigm 3169011B CD3 UCHT1 170Er Fluidigm 3170001B CD97 VIM3b 171Yb Fluidigm 3171015B CD9 SN4_C3-3A2 172Yb Fluidigm 3172010B HLA-DR L243 174Yb Fluidigm 3174001B CD31 MEM-05 175Lu Exbio 11-273-C100; 190516 CD56 (NCAM) NCAM16.2 176Yb Fluidigm 3176008B aSMA 1A4 141Pr Fluidigm 3141017D pSmad1 (Ser463/465)/ Smad5 (Ser463/465)/ Smad9 (Ser465/467) D5B10 151Eu Cell Signaling #12428; 191209 Stat1 (Y701) 58D6 153Eu Fluidigm 3153003A Vimentin D21H3 154Sm Fluidigm 3154014A pSmad2 (Ser465/Ser467) E8F3R 155Gd Cell Signaling #18338; 181129 pStat3 (Y70) 4/P-STAT3 158Gd Fluidigm 3158005A pNF-kBp65 (S536) 93H1 161Dy Cell Signaling #3033;170313 pAkt (S473) D9E 163Dy Cell Signaling #4060; 170313 Active b-catenin (Ser45) D2U8Y 164Dy Cell Signaling #19807; 181129 Ki-67 B56 168Er Fluidigm 3168007B PanCK C-11 173Yb Exbio 11-108-C100; 180919 CD298 REA217 N/A Miltenyi 130-122-331; N/A HLA-I W6/32 N/A Bxcell BE0079; N/A Chemicals Platinum (195Pt, 196Pt) Fluidigm 201195, Recombinase Polymerase Amplification:Article Title: Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Article Snippet: .. Mass cytometry Marker Clone Metal Source Cat. no; home-made LOT identifier CD45 HI30 Y89 Fluidigm 3089003B CD28 CD28.2 142Nd Bxcell BE0291; 180116 CD49f GoH3 143Nd Biolegend 313602; 180906 CD69 FN50 144Nd Fluidigm 3144018B CD4 RPA-T4 145Nd Fluidigm 3145001B CD8a RPA-T8 146Nd Fluidigm 3146001B ITGB5 AST-3 T 147Sm Biolegend 345202; 180919 CD111 R1.302 148Nd Biolegend 340402;180906 CD38 HIT2 149Sm Exbio 11-366-C100, 190425 CD112 TX31 150Nd Biolegend 337402; 180919 EpCAM 9C4 152Sm Biolegend 324229; 180919 CD29 TS2/16 156Gd Fluidigm 3156007B ROR-1 2A2 159Tb Miltenyi Biotec 130-98-243; 191209 CD14 M5E2 160Gd Fluidigm 3160001B CD49c ASC-1 162Dy Biolegend 343802; 180906 CD24 ML5 165Ho Biolegend 311127; 181129 CD44 BJ18 166Er Fluidigm 3166001B CD90 5E10 167Er Biolegend 328129; 180919 CD19 HIB19 169Tm Fluidigm 3169011B CD3 UCHT1 170Er Fluidigm 3170001B CD97 VIM3b 171Yb Fluidigm 3171015B CD9 SN4_C3-3A2 172Yb Fluidigm 3172010B HLA-DR L243 174Yb Fluidigm 3174001B CD31 MEM-05 175Lu Exbio 11-273-C100; 190516 CD56 (NCAM) NCAM16.2 176Yb Fluidigm 3176008B aSMA 1A4 141Pr Fluidigm 3141017D pSmad1 (Ser463/465)/ Smad5 (Ser463/465)/ Smad9 (Ser465/467) D5B10 151Eu Cell Signaling #12428; 191209 Stat1 (Y701) 58D6 153Eu Fluidigm 3153003A Vimentin D21H3 154Sm Fluidigm 3154014A pSmad2 (Ser465/Ser467) E8F3R 155Gd Cell Signaling #18338; 181129 pStat3 (Y70) 4/P-STAT3 158Gd Fluidigm 3158005A pNF-kBp65 (S536) 93H1 161Dy Cell Signaling #3033;170313 pAkt (S473) D9E 163Dy Cell Signaling #4060; 170313 Active b-catenin (Ser45) D2U8Y 164Dy Cell Signaling #19807; 181129 Ki-67 B56 168Er Fluidigm 3168007B PanCK C-11 173Yb Exbio 11-108-C100; 180919 CD298 REA217 N/A Miltenyi 130-122-331; N/A HLA-I W6/32 N/A Bxcell BE0079; N/A Chemicals Platinum (195Pt, 196Pt) Fluidigm 201195, AST Assay:Article Title: Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Article Snippet: .. Mass cytometry Marker Clone Metal Source Cat. no; home-made LOT identifier CD45 HI30 Y89 Fluidigm 3089003B CD28 CD28.2 142Nd Bxcell BE0291; 180116 CD49f GoH3 143Nd Biolegend 313602; 180906 CD69 FN50 144Nd Fluidigm 3144018B CD4 RPA-T4 145Nd Fluidigm 3145001B CD8a RPA-T8 146Nd Fluidigm 3146001B ITGB5 AST-3 T 147Sm Biolegend 345202; 180919 CD111 R1.302 148Nd Biolegend 340402;180906 CD38 HIT2 149Sm Exbio 11-366-C100, 190425 CD112 TX31 150Nd Biolegend 337402; 180919 EpCAM 9C4 152Sm Biolegend 324229; 180919 CD29 TS2/16 156Gd Fluidigm 3156007B ROR-1 2A2 159Tb Miltenyi Biotec 130-98-243; 191209 CD14 M5E2 160Gd Fluidigm 3160001B CD49c ASC-1 162Dy Biolegend 343802; 180906 CD24 ML5 165Ho Biolegend 311127; 181129 CD44 BJ18 166Er Fluidigm 3166001B CD90 5E10 167Er Biolegend 328129; 180919 CD19 HIB19 169Tm Fluidigm 3169011B CD3 UCHT1 170Er Fluidigm 3170001B CD97 VIM3b 171Yb Fluidigm 3171015B CD9 SN4_C3-3A2 172Yb Fluidigm 3172010B HLA-DR L243 174Yb Fluidigm 3174001B CD31 MEM-05 175Lu Exbio 11-273-C100; 190516 CD56 (NCAM) NCAM16.2 176Yb Fluidigm 3176008B aSMA 1A4 141Pr Fluidigm 3141017D pSmad1 (Ser463/465)/ Smad5 (Ser463/465)/ Smad9 (Ser465/467) D5B10 151Eu Cell Signaling #12428; 191209 Stat1 (Y701) 58D6 153Eu Fluidigm 3153003A Vimentin D21H3 154Sm Fluidigm 3154014A pSmad2 (Ser465/Ser467) E8F3R 155Gd Cell Signaling #18338; 181129 pStat3 (Y70) 4/P-STAT3 158Gd Fluidigm 3158005A pNF-kBp65 (S536) 93H1 161Dy Cell Signaling #3033;170313 pAkt (S473) D9E 163Dy Cell Signaling #4060; 170313 Active b-catenin (Ser45) D2U8Y 164Dy Cell Signaling #19807; 181129 Ki-67 B56 168Er Fluidigm 3168007B PanCK C-11 173Yb Exbio 11-108-C100; 180919 CD298 REA217 N/A Miltenyi 130-122-331; N/A HLA-I W6/32 N/A Bxcell BE0079; N/A Chemicals Platinum (195Pt, 196Pt) Fluidigm 201195, Immunohistochemistry:Article Title: Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. Article Snippet: .. Mass cytometry Marker Clone Metal Source Cat. no; home-made LOT identifier CD45 HI30 Y89 Fluidigm 3089003B CD28 CD28.2 142Nd Bxcell BE0291; 180116 CD49f GoH3 143Nd Biolegend 313602; 180906 CD69 FN50 144Nd Fluidigm 3144018B CD4 RPA-T4 145Nd Fluidigm 3145001B CD8a RPA-T8 146Nd Fluidigm 3146001B ITGB5 AST-3 T 147Sm Biolegend 345202; 180919 CD111 R1.302 148Nd Biolegend 340402;180906 CD38 HIT2 149Sm Exbio 11-366-C100, 190425 CD112 TX31 150Nd Biolegend 337402; 180919 EpCAM 9C4 152Sm Biolegend 324229; 180919 CD29 TS2/16 156Gd Fluidigm 3156007B ROR-1 2A2 159Tb Miltenyi Biotec 130-98-243; 191209 CD14 M5E2 160Gd Fluidigm 3160001B CD49c ASC-1 162Dy Biolegend 343802; 180906 CD24 ML5 165Ho Biolegend 311127; 181129 CD44 BJ18 166Er Fluidigm 3166001B CD90 5E10 167Er Biolegend 328129; 180919 CD19 HIB19 169Tm Fluidigm 3169011B CD3 UCHT1 170Er Fluidigm 3170001B CD97 VIM3b 171Yb Fluidigm 3171015B CD9 SN4_C3-3A2 172Yb Fluidigm 3172010B HLA-DR L243 174Yb Fluidigm 3174001B CD31 MEM-05 175Lu Exbio 11-273-C100; 190516 CD56 (NCAM) NCAM16.2 176Yb Fluidigm 3176008B aSMA 1A4 141Pr Fluidigm 3141017D pSmad1 (Ser463/465)/ Smad5 (Ser463/465)/ Smad9 (Ser465/467) D5B10 151Eu Cell Signaling #12428; 191209 Stat1 (Y701) 58D6 153Eu Fluidigm 3153003A Vimentin D21H3 154Sm Fluidigm 3154014A pSmad2 (Ser465/Ser467) E8F3R 155Gd Cell Signaling #18338; 181129 pStat3 (Y70) 4/P-STAT3 158Gd Fluidigm 3158005A pNF-kBp65 (S536) 93H1 161Dy Cell Signaling #3033;170313 pAkt (S473) D9E 163Dy Cell Signaling #4060; 170313 Active b-catenin (Ser45) D2U8Y 164Dy Cell Signaling #19807; 181129 Ki-67 B56 168Er Fluidigm 3168007B PanCK C-11 173Yb Exbio 11-108-C100; 180919 CD298 REA217 N/A Miltenyi 130-122-331; N/A HLA-I W6/32 N/A Bxcell BE0079; N/A Chemicals Platinum (195Pt, 196Pt) Fluidigm 201195, |